SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: robwins who wrote (420)12/12/1997 3:34:00 PM
From: BigKNY3  Respond to of 9523
 
Rob: The FDA gave the Viagra NDA submission a 6 month "priority review" in October, 1997.

No FDA panel information has been announced. A panel may not be necessary. For example, Aricept never had an FDA Panel review.

Final Viagra NDA approval or rejection should be announced no later than April, 1998. To date, every completed priority reviewed NDA has received FDA approval.

BigKNY3


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News